Kinan Alhallak

Years Active: 2020-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kinan Alhallak, Jennifer Sun, Amanda Jeske, Chaelee Park, Jessica Yavner, Hannah Bash, Berit Lubben, Olamide Adebayo, Ayah Khaskiah, Abdel Kareem Azab
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers 13 (12) (2021)
Kinan Alhallak, Pilar de la Puente, Amanda Jeske, Jennifer Sun, Barbara Muz, Michael P Rettig, Ilyas Sahin, Ellen L Weisberg, James D Griffin, John L Reagan, John F DiPersio, Abdel Kareem Azab
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance. Leukemia & lymphoma 62 (10) (2021)
Cinzia Federico, Kinan Alhallak, Jennifer Sun, Kathleen Duncan, Feda Azab, Gail P Sudlow, Pilar de la Puente, Barbara Muz, Vaishali Kapoor, Luna Zhang, Fangzheng Yuan, Matea Markovic, Joseph Kotsybar, Katherine Wasden, Nicole Guenthner, Shannon Gurley, Justin King, Daniel Kohnen, Noha Nabil Salama, Dinesh Thotala, Dennis E Hallahan, Ravi Vij, John F DiPersio, Samuel Achilefu, Abdel Kareem Azab
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma. Nature communications 11 (1) (2020)

Kinan Alhallak.css-eqlu8i{font-size:small;padding-left:4px;}